Related Experiment Videos
Genetic aspects of the hemostatic system in cerebrovascular disease
1Academic Unit of Molecular Vascular Medicine, Research School of Medicine, University of Leeds, Leeds, United Kingdom.
Insights
Stroke is a leading cause of death, and effective prevention requires identifying genetic risk factors. This review explores the genetic basis of cerebrovascular disease (CVD) and the role of the hemostatic system in stroke risk.
Area of Science:
- Neuroscience
- Genetics
- Epidemiology
Background:
- Cerebrovascular disease (CVD) remains a major cause of mortality, with current treatments offering limited long-term benefits.
- Stroke prevention is crucial, necessitating identification of risk factors and high-risk populations.
- Atherosclerosis underlies ischemic CVD, driven by complex gene-environment interactions.
Purpose of the Study:
- To review evidence supporting a genetic basis for stroke.
- To evaluate the hemostatic system as a significant risk factor for stroke.
- To examine the genetic regulation of hemostatic proteins implicated in stroke.
Main Methods:
- Review of existing literature on cerebrovascular disease (CVD) and stroke.
- Analysis of genetic factors contributing to CVD pathogenesis.
- Evaluation of molecular biology techniques (e.g., PCR, sequencing) in CVD research.
Main Results:
- Accumulating evidence suggests a significant genetic component in stroke development.
- The hemostatic system is identified as a key risk factor in cerebrovascular disease (CVD).
- Genetic regulation of specific hemostatic proteins influences stroke risk.
Conclusions:
- Understanding the genetic underpinnings of stroke is vital for effective prevention strategies.
- Targeting the hemostatic system and its genetic regulation may offer new avenues for stroke prevention.
- Further research utilizing molecular epidemiology is needed to fully elucidate CVD pathogenesis.
Abstract:
Despite considerable research into the pathogenesis of cerebrovascular disease (CVD), acute stroke is the third most common cause of mortality in the Western world. The clinical management of acute stroke is largely supportive, although evidence is emerging for the benefit of early pharmacologic intervention. Even when the benefits of these therapies are accounted for, a significant proportion of patients remain disabled or die. Accordingly, stroke prevention is likely to offer the most effective manner of reducing stroke incidence. However, effective prevention depends on a reliable means of identifying and treating the risk factors associated with stroke and possibly targeting preventive measures at high-risk groups. Atherosclerosis is the process responsible for the development of ischemic CVD, and evidence is accumulating to suggest that these disorders are multifactorial, resulting from a complex series of interactions between genes and the environment. The outward expression of the disease, or the disease phenotype, is in part the product of gene-gene and gene-environment interactions. Research methods harnessing molecular biology techniques, including polymerase chain reaction (PCR) and sequencing have, in contrast to coronary artery disease (CAD), been under-utilized when it comes to furthering our understanding of the molecular epidemiology of CVD. This article reviews the evidence that stroke has a genetic basis and that the hemostatic system is an important risk factor for stroke. The genetic regulation of a number of these hemostatic proteins is evaluated.